安慰剂
芬戈莫德
医学
耐受性
多发性硬化
不利影响
随机对照试验
内科学
胃肠病学
病理
免疫学
替代医学
作者
Paul O’Connor,Giancarlo Comi,Xavier Montalbán,Jack P. Antel,EW Radue,Ana de Vera,H. Pöhlmann,Ludwig Kappos
出处
期刊:Neurology
[Lippincott Williams & Wilkins]
日期:2009-01-02
卷期号:72 (1): 73-79
被引量:190
标识
DOI:10.1212/01.wnl.0000338569.32367.3d
摘要
Once-daily oral treatment with FTY720, 1.25 or 5.0 mg, for up to 2 years, was well tolerated and was associated with low relapse rates and lesion activity.
科研通智能强力驱动
Strongly Powered by AbleSci AI